Total Payments
$6,654
2024 Payments
$1,323
Companies
28
Transactions
332
Medicare Patients
1,645
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$6,580 (98.9%)
Education$74.68 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,580 | 330 | 98.9% |
| Education | $74.68 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $914.86 | 46 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $850.29 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $651.62 | 29 | $0 (2024) |
| ABBVIE INC. | $613.77 | 35 | $0 (2024) |
| UCB, Inc. | $610.90 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $532.88 | 31 | $0 (2023) |
| PFIZER INC. | $516.37 | 26 | $0 (2024) |
| Lilly USA, LLC | $437.72 | 25 | $0 (2024) |
| Horizon Therapeutics plc | $232.79 | 10 | $0 (2023) |
| GlaxoSmithKline, LLC. | $231.24 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,323 | 60 | Novartis Pharmaceuticals Corporation ($360.42) |
| 2023 | $954.35 | 41 | Novartis Pharmaceuticals Corporation ($175.04) |
| 2022 | $665.69 | 29 | Janssen Biotech, Inc. ($171.88) |
| 2021 | $454.32 | 21 | UCB, Inc. ($90.27) |
| 2020 | $412.03 | 21 | Amgen Inc. ($111.30) |
| 2019 | $800.96 | 45 | Amgen Inc. ($164.21) |
| 2018 | $1,132 | 71 | UCB, Inc. ($166.80) |
| 2017 | $912.17 | 44 | Amgen Inc. ($158.40) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Immunology | ||||||
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Bone Health | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.37 | General |
| Category: Immunology | ||||||
| 11/06/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Immunology | ||||||
| 10/18/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 488 | 65,208 | $794,016 | $377,698 |
| 2022 | 11 | 508 | 50,349 | $623,855 | $321,611 |
| 2021 | 9 | 387 | 48,451 | $569,965 | $360,989 |
| 2020 | 8 | 262 | 1,679 | $112,677 | $63,465 |
Total Patients
1,645
Total Services
165,687
Medicare Billing
$1.1M
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 18 | 61,600 | $539,000 | $241,385 | 44.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 24 | 2,520 | $65,520 | $45,991 | 70.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 419 | $83,800 | $41,961 | 50.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 45 | 376 | $49,632 | $23,520 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $20,750 | $11,169 | 53.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 46 | $18,400 | $5,178 | 28.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 17 | 32 | $4,800 | $2,608 | 54.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 40 | $6,000 | $2,572 | 42.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 30 | $2,550 | $1,565 | 61.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 27 | $1,755 | $1,066 | 60.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 16 | $1,600 | $572.40 | 35.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 19 | $209.00 | $109.36 | 52.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 22 | 47,600 | $416,500 | $213,017 | 51.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 23 | 1,860 | $48,360 | $31,888 | 65.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 324 | $64,800 | $30,828 | 47.6% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 45 | 273 | $36,036 | $18,364 | 51.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $32,750 | $16,991 | 51.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 11 | 27 | $10,800 | $3,280 | 30.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 21 | 35 | $5,250 | $2,619 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 33 | $4,950 | $2,453 | 49.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 27 | $2,700 | $1,170 | 43.3% |
| 76882 | Limited ultrasound scan of joint or other extremity structure lacking blood vessels | Office | 2022 | 16 | 20 | $1,500 | $903.55 | 60.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 17 | 19 | $209.00 | $97.04 | 46.4% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 11 | 46,400 | $406,000 | $270,127 | 66.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 318 | $59,775 | $31,602 | 52.9% |
About Dr. Primaljyot Bhatia, M.D
Dr. Primaljyot Bhatia, M.D is a Rheumatology healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205069002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Primaljyot Bhatia, M.D has received a total of $6,654 in payments from pharmaceutical and medical device companies, with $1,323 received in 2024. These payments were reported across 332 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,580).
As a Medicare-enrolled provider, Bhatia has provided services to 1,645 Medicare beneficiaries, totaling 165,687 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Internal Medicine
- Location Catonsville, MD
- Active Since 08/26/2009
- Last Updated 03/26/2014
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205069002
Products in Payments
- Cimzia (Drug) $583.64
- ORENCIA (Biological) $532.88
- Enbrel (Biological) $483.34
- XELJANZ (Drug) $440.58
- TREMFYA (Drug) $343.58
- COSENTYX (Biological) $314.83
- ILARIS (Drug) $309.76
- RINVOQ (Biological) $305.59
- TALTZ (Drug) $278.72
- KRYSTEXXA (Biological) $272.90
- BENLYSTA (Biological) $231.24
- COSENTYX (Drug) $225.70
- EVENITY (Biological) $220.10
- SIMPONI ARIA (Biological) $206.03
- Humira (Biological) $147.35
- ACTHAR (Biological) $119.24
- PURIFIED CORTROPHIN GEL (Drug) $117.93
- SAPHNELO (Biological) $110.97
- LUPKYNIS (Drug) $106.05
- SKYRIZI (Biological) $104.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Catonsville
Dr. Jazibeh Qureshi, M.d, M.D
Rheumatology — Payments: $19,928
Rheumatology $19,928
Dr. Ebrahim Talebi Quje, M.d, M.D
Rheumatology — Payments: $14,602
Rheumatology $14,602
Dr. Seyed Hootan Forghani Saeidabadi, M.d, M.D
Rheumatology — Payments: $14,325
Rheumatology $14,325
Dr. Jeffrey Landis, M.d, M.D
Rheumatology — Payments: $7,389
Rheumatology $7,389
Dr. Monica Stewart, M.d, M.D
Rheumatology — Payments: $1,228
Rheumatology $1,228